CorMedix (CRMD) Other financing activities (2010 - 2025)

CorMedix (CRMD) has 13 years of Other financing activities data on file, last reported at $138808.0 in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities rose 107.34% year-over-year to $138808.0; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 1117.44% YoY), and the FY2025 full-year result was $188000.0, up 6166.67% from the prior year.
• Other financing activities improved to $138808.0 in Q4 2025, from $49192.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.2 million in Q1 2023 to a low of -$7.0 million in Q2 2023.
• A 4-year average of $145906.2 and a median of $49192.0 in 2025 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities plunged 100.13% in 2021 and surged 8440.0% in 2024, its largest moves.
• Tracing CRMD's Other financing activities over 4 years: stood at $27851.0 in 2021, then declined by 28.19% to $20000.0 in 2023, then tumbled by 9556.42% to -$1.9 million in 2024, then soared by 107.34% to $138808.0 in 2025.
• Business Quant data shows CRMD's Other financing activities at $138808.0 in Q4 2025, $49192.0 in Q3 2025, and $1.1 million in Q2 2025.